Reaction Details |
| Report a problem with these data |
Target | Nuclear receptor ROR-beta |
---|
Ligand | BDBM50548025 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2019545 (CHEMBL4673123) |
---|
EC50 | 8400±n/a nM |
---|
Citation | Liu, Q; Batt, DG; Weigelt, CA; Yip, S; Wu, DR; Ruzanov, M; Sack, JS; Wang, J; Yarde, M; Li, S; Shuster, DJ; Xie, JH; Sherry, T; Obermeier, MT; Fura, A; Stefanski, K; Cornelius, G; Khandelwal, P; Tino, JA; Macor, JE; Salter-Cid, L; Denton, R; Zhao, Q; Dhar, TGM Novel Tricyclic Pyroglutamide Derivatives as Potent ROR?t Inverse Agonists Identified using a Virtual Screening Approach. ACS Med Chem Lett11:2510-2518 (2020) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Nuclear receptor ROR-beta |
---|
Name: | Nuclear receptor ROR-beta |
Synonyms: | NR1F2 | Nuclear receptor RZR-beta | Nuclear receptor subfamily 1 group F member 2 | RORB | RORB_HUMAN | RZRB | Retinoid-related orphan receptor-beta |
Type: | PROTEIN |
Mol. Mass.: | 53227.30 |
Organism: | Homo sapiens (Human) |
Description: | ChEMBL_107979 |
Residue: | 470 |
Sequence: | MCENQLKTKADATAQIEVIPCKICGDKSSGIHYGVITCEGCKGFFRRSQQNNASYSCPRQ
RNCLIDRTNRNRCQHCRLQKCLALGMSRDAVKFGRMSKKQRDSLYAEVQKHQQRLQEQRQ
QQSGEAEALARVYSSSISNGLSNLNNETSGTYANGHVIDLPKSEGYYNVDSGQPSPDQSG
LDMTGIKQIKQEPIYDLTSVPNLFTYSSFNNGQLAPGITMTEIDRIAQNIIKSHLETCQY
TMEELHQLAWQTHTYEEIKAYQSKSREALWQQCAIQITHAIQYVVEFAKRITGFMELCQN
DQILLLKSGCLEVVLVRMCRAFNPLNNTVLFEGKYGGMQMFKALGSDDLVNEAFDFAKNL
CSLQLTEEEIALFSSAVLISPDRAWLIEPRKVQKLQEKIYFALQHVIQKNHLDDETLAKL
IAKIPTITAVCNLHGEKLQVFKQSHPEIVNTLFPPLYKELFNPDCATGCK
|
|
|
BDBM50548025 |
---|
n/a |
---|
Name | BDBM50548025 |
Synonyms: | CHEMBL4782326 |
Type | Small organic molecule |
Emp. Form. | C30H29F9N2O5S |
Mol. Mass. | 700.612 |
SMILES | [H][C@@]12CCc3cc(ccc3[C@@]1(CCN2C(=O)[C@@H]1C[C@@H](F)C(=O)N1CC(C)(C)O)S(=O)(=O)c1ccc(F)cc1)C(F)(C(F)(F)F)C(F)(F)F |r| |
Structure |
|